CAJ | 학술논문

心力衰竭（心衰）指心脏结构或功能性疾病导致心室充盈及（或）射血能力受损而引起的一组综合征。利尿剂在心力衰竭治疗中占重要地位，是治疗急性呼吸困难和维持慢性心衰血容量稳定的一线用药。合理使用利尿剂是其他治疗心衰药物取得成功的关键因素之一。利尿剂种类较多，近年有关利尿剂治疗心衰的研究不断涌现，尤其是托拉塞米、醛固酮受体拮抗剂、托伐普坦等在心衰治疗中的应用有较多的文献报道，该文就相关研究进展予以综述。
심력쇠갈（심쇠）지심장결구혹공능성질병도치심실충영급（혹）사혈능력수손이인기적일조종합정。이뇨제재심력쇠갈치료중점중요지위，시치료급성호흡곤난화유지만성심쇠혈용량은정적일선용약。합리사용이뇨제시기타치료심쇠약물취득성공적관건인소지일。이뇨제충류교다，근년유관이뇨제치료심쇠적연구불단용현，우기시탁랍새미、철고동수체길항제、탁벌보탄등재심쇠치료중적응용유교다적문헌보도，해문취상관연구진전여이종술。
Heart failure refers to a series of clinical syndromes of impaired ability of the ventricle to fill or eject blood results from abnormality of cardiac structure or functional diseaseshe.Diuretics play an importantrole in heart failure therapy,they are the first-line drugs in treating acute dyspnea and maintaining thestability of blood volume in patients with chronic heart failure.The rational use of diuretics is one of the keyfactors that influence on the successfulness of other medicines in treating heart failure.In recent years,researcheson diuretics in treating heart failure are constantly emerging,especially on torasemide,aldosterone receptorantagonists,tolvaptan,etc.Here is to make a review of the advances in such researches .